President Yoweri Museveni has met and held talks with Mr. Grey Frandsen, the CEO of Oxitec, a prominent biotech company that has over 20 years experience in the field of malaria research. Away from malaria, Oxitec is also into Animal and Agricultural research.
The President expressed his delight in Oxitec’s collaboration with the Uganda Virus Research Institute, aimed at tackling the pervasive issue of malaria in the country.
During their meeting on Tuesday, President Museveni conveyed his satisfaction upon learning about the joint efforts planned by Oxitec and the Uganda Virus Research Institute. The collaboration, as disclosed by Mr. Frandsen, is strategically designed to confront the challenges posed by malaria, a disease that has significantly impacted the nation’s health landscape.
“Today, I welcomed Mr. Grey Frandsen, the CEO of Oxitec, a leading biotech company. I was glad to hear from him that they are teaming up with the Uganda Virus Research Institute to combat malaria. I welcome them, and as the government, we shall support this partnership,” stated President Museveni, emphasizing the importance of unified efforts in addressing public health crises.
The initiative outlined by Oxitec and the Uganda Virus Research Institute aligns with the government’s commitment to bolstering healthcare endeavors. President Museveni assured that the government stands ready to offer steadfast support to this collaborative venture.
Malaria remains a persistent health concern in Uganda, posing a significant challenge to public health infrastructure. The partnership between Oxitec and the Uganda Virus Research Institute signifies a promising stride in the ongoing battle against the disease.
The joint efforts aim to leverage innovative biotech solutions to mitigate the spread of malaria-transmitting mosquitoes. Oxitec’s expertise in biotechnology coupled with the research capabilities of the Uganda Virus Research Institute are anticipated to yield groundbreaking advancements in combating the disease.
President Museveni commended the proactive approach taken by Oxitec and the Uganda Virus Research Institute, underscoring the necessity for such partnerships to drive impactful change in healthcare.
As the collaboration gains momentum, stakeholders anticipate that this concerted effort will not only curb the prevalence of malaria but also pave the way for advancements in healthcare research and interventions in Uganda.
The President’s endorsement of this partnership reaffirms the government’s commitment to fostering innovative solutions and collaborations in the healthcare sector. With joint determination and support, this alliance aims to chart a course towards a healthier and malaria-resistant Uganda.
In the same meeting the President thanked Calvin Echodu, the NRM Flag bearer for Soroti City West based in the US for being mindful of providing technological solutions to the challenges posed by malaria to his country Uganda. He thanked him for his role in fighting malaria using his NGO called Pilgrim that led to indoor spraying in some of the districts in Teso. The President believes if harnessed well, Oxitec technology will help in dealing with Funestus Anopheles mosquito that is mainly in large water bodies hence reducing the threat.